X4 Pharmaceuticals, Inc
live · Yahoo FinanceLimited buying: $33.2M bought (counted up to $5.0M); 9 distinct insiders. Holding it back: largest buyer: GORDON CARL L (Director), 15% of the dollars.
Score, not a recommendation.
partial dataAn input is missing, usually the market cap or the price history. A missing input counts as neutral in the score and is never estimated. Price history is incomplete; missing inputs count as neutral in the score.
same price, one day All 17 purchases were at $10.00 on 2017-11-20. That pattern also occurs in IPO or conversion subscriptions, which are not open-market conviction buying.
Price and insider purchases
Live chart from Yahoo Finance, loaded through this server; our daily closes when it is unavailable.
Loading price history…
How the score adds up
How each input is counted →| Input | Strength | Points |
|---|---|---|
| $33.2M bought (counted up to $5.0M)The dollars the insiders bought, a purchase reported jointly counted once, counted from $131. Each tenfold adds 12.4 points, up to $5.0M; more adds nothing. The bar is empty at $10.0K and full at $5.0M. | 100% | +57 |
| 9 distinct insidersHow many different insiders bought. Each extra insider adds less than the one before (the points follow the log of the count: 4.3 per doubling). The bar is full at 10 insiders. | 95% | +14 |
| No CEO among the buyersWhether the chief executive is among the buyers: 10.6 points when yes. | 0% | +0 |
| Stock 0% below its 1-year highHow far the stock had fallen from its highest close of the past year, at the close before the buying. Every 10% of fall adds 1.9 points. A fall beyond 30% adds nothing more. The bar is full at a 30% fall. | 0% | +0 |
| 0 days from first to last purchaseDays between the first and the last purchase. Each day takes off 0.11 points: buying close together keeps more. The bar is empty at 60 days. | 100% | +0 |
| Routine or plan purchases: 0% of the dollars | 100% | +0 |
| Largest buyer: GORDON CARL L (Director), 15% of the dollars | 96% | -2 |
| Match scoreA score from 0 to 100 worked out from the dollars bought, the number of insiders, whether a CEO bought, how far the stock had fallen, how spread out the purchases were and how much came from one buyer. Its weights were calibrated on past clusters. It is the default ranking of the lists and it decides which clusters get the AI review. It describes the buying; it is not a forecast. | 69 | |
| Pipeline flagsPoints taken off because the filings themselves show this buying was an offering, a plan or a 10b5-1 programme. Used only when there is no AI review; from Form 4 footnotes, 8-K filings and prices. (IPO or offering) | -14 | |
| Insider ScoreThe number from 0 to 100 shown on each cluster and used to rank the lists. By default it is the match score, plus the points of the AI review when there is one. It describes the buying; it is not a forecast or a recommendation. | 55 | |
Why are they buying?
No explanation has been generated for this cluster. The filings in the table below are the primary evidence.
| Date | InsiderAn officer or director of a company, or an owner of more than 10% of its shares. The law requires them to report their trades in the company's stock to the SEC. | Role | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2017-11-20 | Ross Michael Jay history of Ross Michael Jay's purchases | Director | 500,000 | $10.00 avg | $5.0M | |
| 2017-11-20 | Ross Michael Jay | 483,448 | $10.00 | $4.8M | SEC filing for Ross Michael Jay (opens in a new tab) | |
| 2017-11-20 | Ross Michael Jay | 16,552 | $10.00 | $165.5K | SEC filing for Ross Michael Jay (opens in a new tab) | |
| 2017-11-20 | Flint Jonathan A history of Flint Jonathan A's purchases | 10% owner | 500,000 | $10.00 avg | $5.0M | |
| 2017-11-20 | Flint Jonathan A | 482,467 | $10.00 | $4.8M | SEC filing for Flint Jonathan A (opens in a new tab) | |
| 2017-11-20 | Flint Jonathan A | 9,403 | $10.00 | $94.0K | SEC filing for Flint Jonathan A (opens in a new tab) | |
| 2017-11-20 | Flint Jonathan A | 3,305 | $10.00 | $33.0K | SEC filing for Flint Jonathan A (opens in a new tab) | |
| 2017-11-20 | Flint Jonathan A | 4,825 | $10.00 | $48.2K | SEC filing for Flint Jonathan A (opens in a new tab) | |
| 2017-11-20 | GORDON CARL L history of GORDON CARL L's purchases | Director | 500,000 | $10.00 | $5.0M | SEC filing for GORDON CARL L (opens in a new tab) |
| 2017-11-20 | MCGUIRE TERRANCE history of MCGUIRE TERRANCE's purchases | Director | 500,000 | $10.00 avg | $5.0M | |
| 2017-11-20 | MCGUIRE TERRANCE | 482,467 | $10.00 | $4.8M | SEC filing for MCGUIRE TERRANCE (opens in a new tab) | |
| 2017-11-20 | MCGUIRE TERRANCE | 9,403 | $10.00 | $94.0K | SEC filing for MCGUIRE TERRANCE (opens in a new tab) | |
| 2017-11-20 | MCGUIRE TERRANCE | 3,305 | $10.00 | $33.0K | SEC filing for MCGUIRE TERRANCE (opens in a new tab) | |
| 2017-11-20 | MCGUIRE TERRANCE | 4,825 | $10.00 | $48.2K | SEC filing for MCGUIRE TERRANCE (opens in a new tab) | |
| 2017-11-20 | SV LIFE SCIENCES FUND V LP history of SV LIFE SCIENCES FUND V LP's purchases | 10% owner | 500,000 | $10.00 avg | $5.0M | |
| 2017-11-20 | SV LIFE SCIENCES FUND V LP | 483,448 | $10.00 | $4.8M | SEC filing for SV LIFE SCIENCES FUND V LP (opens in a new tab) | |
| 2017-11-20 | SV LIFE SCIENCES FUND V LP | 16,552 | $10.00 | $165.5K | SEC filing for SV LIFE SCIENCES FUND V LP (opens in a new tab) | |
| 2017-11-20 | Nessi Claudio history of Nessi Claudio's purchases | Director | 300,000 | $10.00 | $3.0M | SEC filing for Nessi Claudio (opens in a new tab) |
| 2017-11-20 | NeoMed Innovation V L.P. history of NeoMed Innovation V L.P.'s purchases | 10% owner | 300,000 | $10.00 | $3.0M | SEC filing for NeoMed Innovation V L.P. (opens in a new tab) |
| 2017-11-20 | Gerngross Tillman U. history of Gerngross Tillman U.'s purchases | Director | 200,000 | $10.00 | $2.0M | SEC filing for Gerngross Tillman U. (opens in a new tab) |
| 2017-11-20 | Muhlenbeck Frank history of Muhlenbeck Frank's purchases | 10% owner | 20,000 | $10.00 | $200.0K | SEC filing for Muhlenbeck Frank (opens in a new tab) |
| Total | $33.2M | |||||